Q1-2021-cover.jpg
I'm a paragraph. I'm connected to your collection through a dataset. To update me, go to the Data Manager. The Data Manager is where you store data to use in your site pages, or collect data from site visitors when they submit a form. This collection in the Data Manager is already set up with some fields and content. To customize it with your own content, you can import a CSV file or simply edit the placeholder text. You can also add more fields which you can connect to other page elements so the content displays on your published site. Remember to sync the collection so your content is live! You can add as many new collections as you need to store or collect data.
Q4 2021

MILESTONES

SERVICE TO DATE  ⤵︎

Community Health Workers

Home Visits 

Clinic Visits 

Q1 2021 PROACTIVE CARE IN MALI  ⤵︎

465,634
450,000
(target)

HOME VISITS

CHW home visits for active case finding, diagnosis, treatment, and follow-up.

30,577
30,000
(target)

CLINIC VISITS

Comprehensive and free clinic-based care.

Peri-urban Site
(Yirimadio, Bamako)

Rural Sites

(Bankass region)

24 H

94.4%
65%
(target)

+

-

+

-

66.8%

24 H

65%
(target)

SPEED OF CARE

Muso CHWs aim to reach and treat every patient within hours of their first symptoms. % : of children under age 5 treated by CHWs within 24 hours in Q1.

*Muso's rural sites consist of passive and proactive workflow arms due to the ProCCM Trial, a Randomized Controlled Trial embedded in our rural care delivery sites. The results of this trial, available in late 2021, will inform the ultimate workflow Bankass sites adopt. We anticipate some indicators listed here are lower than they might be otherwise, as our rural sites are comprised of half passive CHWs, who are not conducting proactive case detection.

 

NB: In order to align with national reporting standards across all health care sites in Mali, Muso’s month runs from the 26th to the 25th.

QUARTER 1 PROGRESS

→ National technical assistance partnership.

→ Future operational sites in the process of being selected.

CÔTE D'IVOIRE

→ National technical assistance partnership.

→ 8 operational sites in rural Mali serving 145,000 people.

→ 1 operational site (+1 under construction) in peri-urban Mali serving 210,000 people.

MALI

MALI

Screen Shot 2021-04-15 at 3.58.23 PM.jpg
Bankass region, ©2021 CNES

Q1 SUCCESSES & CHALLENGES

+ Launching long-term, national-scale partnership in Côte d’Ivoire.

+ Oxygen equipment and training program rolling out across Mali.

- COVID-19 cases rising across our partner countries.

- High rates of vaccine skepticism and global inequalities in distribution have hampered vaccine rollout and uptake.

MALI

CÔTE D'IVOIRE

RESEARCH

Muso’s research pursues four key goals: 

  1. Learning: We pursue research that will answer our central question: how do we cure delay in health care? Our research teaches us how to better serve patients with rapid access to care.

  2. Accountability: Through our research, we hold ourselves accountable to our community partners and patients. Our research enables us to test our assumptions, and determine the extent to which we have fulfilled our commitments. 

  3. National Health System Transformation: We conduct research jointly with government partners, so that they can use findings to inform national policy and practice. 

  4. Changing Global Policy and Practice: Our research is designed to drive global change in what global health funders finance, what technical bodies like the World Health Organization and UNICEF recommend, and how implementers practice.

 

As we ready to launch operations in Côte d’Ivoire, our Research team is determining the optimal research study design to achieve these goals. In Q1, we gathered input from the Ivorian government on their priorities and needs, and are considering various research plans to meet them. We hope to determine our new study design by the end of Q2. 

 

In Mali, data analysis in the ProCCM Trial continues. In Q1, we published two studies using baseline data from our rural sites, the first assessing barriers and influences that help determine women’s use of modern contraceptives and the second examining household factors associated with under-five mortality.

TEAM

For the past thirteen years, Dr. Amadou Beydi Cissé has served Muso in multiple capacities, leading at the forefront of many of our greatest challenges and opportunities for growth. When Muso launched services in the Bankass region in 2016, Dr. Cissé was appointed Rural Site Coordinator, overseeing care delivery across the eight sites that would function as Muso’s boldest operational research project to date: the ProCCM Trial. Dr. Cissé’s leadership has been pivotal in ensuring care providers and researchers are able to continue their work safely, as COVID-19 and violence and insecurity have threatened patients’ lives and access to care within the Bankass region.

 

Dr. Cissé was recently promoted to Muso’s first Country Director for Côte d’Ivoire. In this role, he will guide the team forging Muso’s first expansion outside of Mali, supporting the Ivorian government to build systems that cure delay across their national health care system, and paving the way toward UHC. 

20170225_0024_Muso_TimWerwie.jpg

We want to show that these strategies have been successful in Mali and can also be replicated in other contexts, countries, and at the global level. This is what we are going to implement in Côte d'Ivoire.

FINANCIALS

STATEMENT OF ACTIVITY*  ⤵︎

STATEMENT OF FINANCIAL POSITION*  ⤵︎

TOTAL BUDGET OVER 3 YEARS

$22.6M
Funds to Raise from New Sources

2021-2023

Projections < 70% probability
Received or Committed
Projections ⋝ 70% probability
$7.3M
$9.8M
$11.5M
$51.2M

TOTAL BUDGET

Additional $2M to launch Côte d'Ivoire operations in 2021

⤵︎

YEAR BY YEAR 

Received or Committed

Budget

Projections ⋝ 70% probability

Projections < 70% probability